| TX | HB1293 | Intro
Sine Die | Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program. [Detail][Text][Discuss] | 2023-04-25 To House Human Services Committee |
| TX | HB594 | Intro
Sine Die | Relating to the provision of telepharmacy services. [Detail][Text][Discuss] | 2023-04-17 To House Public Health Committee |
| TX | HB1373 | Intro
Sine Die | Relating to a pilot program for the safe disposal of controlled substance prescription drugs. [Detail][Text][Discuss] | 2023-04-17 To House Public Health Committee |
| TX | HB2079 | Intro
Sine Die | Relating to the authority of pharmacists to order and furnish certain prescription drugs. [Detail][Text][Discuss] | 2023-04-17 To House Public Health Committee |
| TX | HB5129 | Intro
Sine Die | Relating to the delegation to a pharmacy technician of a pharmacist's authority to administer an immunization or vaccine. [Detail][Text][Discuss] | 2023-03-24 To House Public Health Committee |
| TX | HB5298 | Intro
Sine Die | Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances. [Detail][Text][Discuss] | 2023-03-24 To House Public Health Committee |
| TX | HB5249 | Intro
Sine Die | Relating to prohibiting a public entity from providing financial assistance for abortion or abortion-related services; providing civil penalties. [Detail][Text][Discuss] | 2023-03-24 To House State Affairs Committee |
| TX | HB4581 | Intro
Sine Die | Relating to the regulation of the practice of pharmacy. [Detail][Text][Discuss] | 2023-03-22 To House Public Health Committee |
| TX | HB4341 | Intro
Sine Die | Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use. [Detail][Text][Discuss] | 2023-03-21 To House Public Health Committee |
| TX | HB3774 | Intro
Sine Die | Relating to civil and criminal liability for pharmacists and pharmacies that dispense misoprostol. [Detail][Text][Discuss] | 2023-03-20 To House Public Health Committee |
| TX | HB3152 | Intro
Sine Die | Relating to the identification of the country of manufacture on the label for a prescription drug or biological product. [Detail][Text][Discuss] | 2023-03-15 To House Public Health Committee |
| TX | HB3082 | Intro
Sine Die | Relating to a pharmacy, pharmacist, or pharmacy technician decision to not dispense or sell a drug according to religious belief or moral conviction. [Detail][Text][Discuss] | 2023-03-14 To House Public Health Committee |
| TX | HB972 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs. [Detail][Text][Discuss] | 2023-03-02 To House Public Health Committee |
| TX | HB1050 | Intro
Sine Die | Relating to the authority of pharmacists to dispense self-administered hormonal contraceptives. [Detail][Text][Discuss] | 2023-03-02 To House Public Health Committee |
| TX | HB815 | Intro
Sine Die | Relating to distinctive packaging for opioid prescription drugs. [Detail][Text][Discuss] | 2023-03-01 To House Public Health Committee |
| TX | HB816 | Intro
Sine Die | Relating to warning labels for opioid prescription drugs. [Detail][Text][Discuss] | 2023-03-01 To House Public Health Committee |
| TX | HB814 | Intro
Sine Die | Relating to an acknowledgment on receipt of an opioid prescription drug. [Detail][Text][Discuss] | 2023-03-01 To House Public Health Committee |
| TX | HB235 | Intro
Sine Die | Relating to the authority of pharmacists to furnish certain medications. [Detail][Text][Discuss] | 2023-02-23 To House Public Health Committee |